Kyverna Therapeutics, Inc.(KYTX)
Biotechnology
Cell Therapy (CAR-T, etc.)
| Filing Date | Insider | Type | 10b5-1 | Net Shares | Ownership change | Avg. Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| 2025-12-22 | SEIDENBERG BETH C Director | Purchase | +133,333 | +18.12%869,317 | $7.50 | $999,998 | View SEC filing | |
| 2025-12-22 | Westlake BioPartners Fund I, L.P. 10% Owner | Purchase | +133,333 | +18.12%869,317 | $7.50 | $999,998 | View SEC filing | |
| 2025-12-17 | Walker Karen Marie Chief Technology Officer | Sale | -23,998 | -51.46%22,636 | $12.20 | $292,776 | View SEC filing | |
| 2024-02-14 | Vida Ventures, LLC 10% Owner | Purchase | +253,136 | +100.00%253,136 | $22.00 | $5,568,992 | View SEC filing | |
| 2024-02-14 | Bain Capital Life Sciences Investors, LLC 10% Owner | Purchase | +450,000 | +16.58%3,163,868 | $22.00 | $9,900,000 | View SEC filing | |
| 2024-02-13 | GILEAD SCIENCES, INC. 10% Owner | Purchase | +910,000 | +28.29%4,126,119 | $22.00 | $20,020,000 | View SEC filing | |
| 2024-02-12 | Rubin Michael P. Other | Purchase | +450,000 | +100.00%450,000 | $22.00 | $9,900,000 | View SEC filing |
1-7 of 7